11 Tweedy Browne Vertex Pharmaceuticals Trades
Tweedy Browne's position in Vertex Pharmaceuticals is currently worth $18.9M. That's 1.45% of their equity portfolio (18th largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2023. Since then Tweedy Browne bought shares three more times and sold shares on seven occasions. The stake costed the investor $14.3M, netting the investor a gain of 32% so far.
Avg closing price
Price range
Increased shares by 3.2% (+1.24k shares)
Q1 2026
Avg closing price
$468.35
Price range
$433.07
-
$499.17
Increased shares by 0.2% (+83 shares)
Q4 2025
Avg closing price
$431.04
Price range
$402.90
-
$463.13
Increased shares by 4.9% (+1.81k shares)
Q3 2025
Avg closing price
$418.14
Price range
$366.54
-
$479.53
Sold 2.8% shares (-1.06k shares)
Q2 2025
Avg closing price
$460.78
Price range
$421.16
-
$509.50
Sold 5.7% shares (-2.32k shares)
Q1 2025
Avg closing price
$464.34
Price range
$402.49
-
$513.76
Sold 24.2% shares (-13k shares)
Q4 2024
Avg closing price
$461.09
Price range
$397.27
-
$516.74
Sold 1.4% shares (-746 shares)
Q3 2024
Avg closing price
$480.45
Price range
$460.00
-
$505.78
Sold 18.5% shares (-12.4k shares)
Q2 2024
Avg closing price
$434.05
Price range
$392.81
-
$485.53
Sold 0.1% shares (-65 shares)
Q1 2024
Avg closing price
$422.74
Price range
$407.69
-
$446.08
Sold 11.0% shares (-8.24k shares)
Q4 2023
Avg closing price
$369.42
Price range
$343.00
-
$410.68
New holding (+75k shares)
Q3 2023
Avg closing price
$349.73
Price range
$338.18
-
$362.46
